SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zeev Hed who wrote (27)9/15/1996 5:02:00 PM
From: WWS   of 371
 
Zeev, chart of IMMU's price over past year shows a sustained, persistent secular increase of roughly 25% per annum. Superimposed on this trend have been some volatile "spikes" (both up and down) as the "big guys" (as indicated by volume) took or abandoned positions. At the moment, IMMU's price is almost exactly where its long term regression line predicts. And in terms of fundamentals, IMMU seems to have two characteristics likely to attract and retain institutional sponsorship: products near or at commercial release and a deep pipeline. I'm going to be patient with this one, as the signals all seem to be favorable. Bill in St. Louis.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News